TipRanks
HUTCHMED (China) Limited (HK:0013)
:0013
Hong Kong Market
0013
HUTCHMED (China)
RESEARCH TOOLSreports
Want to see HK:0013 full AI Analyst Report?

HUTCHMED (China) (0013) Stock News & Sentiment

8 Followers
HUTCHMED’s Sovleplenib Wins US Orphan Drug Status for Rare Blood Disorder
Premium
Company Announcements
HUTCHMED’s Sovleplenib Wins US Orphan Drug Status for Rare Blood Disorder
3d ago
HUTCHMED to Showcase Savolitinib Lung Cancer Data in Investor Webcast
Premium
Company Announcements
HUTCHMED to Showcase Savolitinib Lung Cancer Data in Investor Webcast
5d ago
HUTCHMED Combination Therapy Delivers Strong Phase III Lung Cancer Results
Premium
Company Announcements
HUTCHMED Combination Therapy Delivers Strong Phase III Lung Cancer Results
6d ago
HUTCHMED’s ORPATHYS Combo Delivers Phase III Survival Gains in MET-Driven Lung Cancer
Premium
Company Announcements
HUTCHMED’s ORPATHYS Combo Delivers Phase III Survival Gains in MET-Driven Lung Cancer
6d ago
HUTCHMED Seals Global HMPL-A830 Licensing Deal With GSK Outside China
Premium
Company Announcements
HUTCHMED Seals Global HMPL-A830 Licensing Deal With GSK Outside China
11d ago
HUTCHMED Backs AstraZeneca’s U.S. Filing for ORPATHYS–TAGRISSO Lung Cancer Combo
Premium
Company Announcements
HUTCHMED Backs AstraZeneca’s U.S. Filing for ORPATHYS–TAGRISSO Lung Cancer Combo
1M ago
HUTCHMED launches first-in-human global trial of novel KRAS-EGFR cancer therapy HMPL-A830
Premium
Company Announcements
HUTCHMED launches first-in-human global trial of novel KRAS-EGFR cancer therapy HMPL-A830
1M ago
More HK:0013 News >

0013 News on the Web

Hutchmed initiates Phase Ia part of trial of HMPL-A830
TipRanks News
Bullish
Citic Securities Remains a Buy on HUTCHMED (China) (HCM)
TipRanks News
Bullish
Huatai Securities Keeps Their Buy Rating on HUTCHMED (China) (HCM)
TipRanks News
Bullish
Positive Report for HUTCHMED (China) (HCM) from Daiwa
TipRanks News
Bullish
HUTCHMED shares jump 17% on US$1.3 billion GSK cancer drug deal
Proactive Investors
Bullish
HUTCHMED Licenses First-in-Class KRAS-EGFR Cancer Therapy to GSK in US$1.3 Billion Deal
TipRanks News
Bullish
HUTCHMED Flags Director’s Link to Insolvent Israeli Medtech Firm, Sees No Impact
TipRanks News
Neutral
Hutchmed announces results from Saffron Phase III trial of Orpathys, Tagrisso
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
HK:0013
Sector Average
Media Buzz
This Week8 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:0013’s Media Buzz Sentiment?
8 articles about HK:0013 were published this week. In an average week, 1.25 articles are published.
    What is HK:0013’s weekly average amount of articles?
    In an average week, 1.25 articles about HK:0013 are published.
      What is HK:0013’s News Sentiment?
      100% of articles about HK:0013 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week